Related Articles
Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib
Overexpression of microRNA‑620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
Downregulation of SOX9 suppresses breast cancer cell proliferation and migration by regulating apoptosis and cell cycle arrest
Antitumor efficacy of the Runx2‑dendritic cell vaccine in triple‑negative breast cancer in vitro